Browser not compatible.
Your computer's internet browser may not be compatible with this system. In order to use this system properly, you will need to update your current browser version or use another compatible browser version such as: Internet Explorer 8+, Mozilla Firefox 4+, Safari 5+, Chrome 14+, Opera 11.5+. Thank you.
Your session will expire in:
ESMO 23rd World Congress on Gastrointestinal Cancer

Barcelona, Spain
30 June -3 July 2021

 
Abstract Submission Deadline:  22 March 2021  16:00 CET



 
Instructions to Submitters
• Ensure all email addresses are correct.
• There are no graphic uploads allowed.
• If you need technical or association assistance, please use the email support form on each page.
• Once you are complete, please click on ‘finalize submission’ on the final page to complete your submission.
• Revisit the site as often as necessary to complete your submission.
• The back and forward browser arrows have been disabled; please use the menu progress bar at the top right hand corner of the pages to return to previous pages.
• Users must use the following browsers: Mozilla Firefox 4+, Safari 5+, Chrome 14+, Opera 11.5+, MS Edge. We do not recommed Internet Explorer.
• At any point in the abstract process, the submitter of the abstract can log into submission to view your abstract details and any correspondence about your submission(s).
Note on email communications: Please add @owpm1.com as a safe sender in your email program. If you do not do this, your email spam filter may prevent you from receiving important emails regarding your submission(s).  For more information on adding safe senders for your mail server, click here
 
Guidelines
Participants interested in presenting data should submit abstracts online by 22 March 2021. Abstracts are subject to acceptance by the Scientific Committee. Once accepted, abstracts will be published in a supplement of Annals of Oncology and scheduled for oral or poster presentation. Acceptance notifications and guidelines for podium and poster presentations will be sent on 16 April 2021. Authors of accepted abstracts who have not registered will have until 6 May 2021 to do so at the early registration rate. After this date, abstracts without registered presenters will be disregarded and not included in the publication.

Abstracts will be accepted in the following categories, and the author should indicate it as either BASIC or CLINICAL by choosing the appropriate category in the online submission system:
 
• Colon Cancer
• Esophageal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer
• Rectal Cancer
• Biliary Tract Cancer
• Neuroendocrine Tumors
• Others (including GIST and Anal Cancer)

Subcategories include:
 
• Biomarkers and Translational Research
• Early and Locally Advanced Disease
• Imaging
• Metastatic Disease
• Pathology
• Preclinical
• Radiotherapy
• Screening/Prevention/Epidemiology
• Surgery
• Trial in Progress
• Others
 

Trials in Progress Abstract Submissions
The 23rd ESMO World Congress on Gastrointestinal Cancer is now accepting Trials in Progress abstract submissions in all phases of clinical research (phase I to phase III).  All abstracts submitted as Trials in Progress are ongoing trials that have not reached any protocol-specific endpoint for analysis and will only require the completion of two sections: Background and Trial Design.  It is a requirement that recruitment must have already begun or have been completed by the abstract submission deadline.

Abstract Guidelines
  • Follow the online instructions
  • Abstracts must be written in English
  • All abstracts are considered for Oral Presentation.  If not accepted for Oral, then ALL submissions will be considered for Poster Presentation
  • The submitted work must not, nor will not have been:
    • published in any journal, or on any web site before 30 June 2021, nor
    • presented at any national or international scientific conference prior to 30 June 2021
    • Encore abstracts will be allowed if they contain new data. During the submission process you will be asked if the abstract has been presented before, when you say yes you will be prompted to submit the original abstract as a reference.
  • Abstract body must have a 500 word count limit
  • Use a concise title
  • List affiliations of author(s) as briefly as possible, with city, province/state and country
  • Maximum number of authors:  22
  • Use standard and well-accepted abbreviations
  • When using references, use standard and well-accepted formats
  • Abstract content should be single-spaced and typed in lower case
  • Abstracts shall be of original research and contain a concise statement of study aim
  • Submit four (4) parts of your abstract: Background, Method, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.
  • Abstract submissions can only be completed and finalized once all authors have submitted their disclosures.  There is an ‘email author’ function to allow for submitters to send reminders to their co-authors to submit disclosures. The disclosure deadline will be the same as the submission deadline.

Developing Nations Travel Awards
A limited number of travel awards are available for investigators from developing nations. Awards are available to investigators from the countries indicated in the 2021 World Bank List of Economies as Low, Lower Middle or Upper Middle Income Economies. The complete list can be found at http://www.worldbank.org

The winners will be awarded free registration to the Congress.

How to Apply for Developing Nations Travel Awards:
  • The candidate must submit an abstract to the ESMO 23rd World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Developing Nations Award
  • The candidate must be the first author of the submitted abstract
  • The work must not have been presented or published before the date of the ESMO 23rd World Congress on Gastrointestinal Cancer
  • Abstracts must be submitted on schedule
  • Candidates should submit:
    • A Curriculum Vitae
    • A 1-3 page description of their interests and current research in gastrointestinal cancer signed and approved by their department chair
The Scientific Committee will select the award winners on the basis of the scientific content of the abstract. Winners will be notified in April 2021.


Young Investigator Awards
A limited number of Young Investigator Best Abstract Awards are available, upon application, to first author (= presenter) to candidates under the age of 35 who submit abstracts considered deserving of recognition.  The winners will be awarded free registration to the Congress.

How do I apply for a young investigator award?
• The candidate must submit an abstract to the ESMO World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Young Investigator Award during submission.
• To be considered for the Young Investigator Award, candidates will be required to submit a brief summary (cannot exceed 500 words) of the findings of the abstract and their relevance to the topics presented at the Congress.
• The age of the candidate should be less than 35 years of age by the submission deadline (Age will be verified).
• The candidate must be the first and presenting author of the submitted abstract.
• The work must not have been presented or published before the date of the ESMO 23rd World Congress on Gastrointestinal Cancer.

The Scientific Committee will select the award winners on the basis of the scientific content of the abstract. Winners will be notified in April 2021.

Late-Breaking Abstract Submissions
The Congress late-breaking policy allows the submission of late-breaking abstracts defined as “high quality, new research findings from randomized phase II or phase III trials with implications for clinical practice or understanding of disease processes.”

An abstract template should be submitted by the regular abstract deadline (22 March).  The template should include: title, author list, and a description of the study.  A final abstract version must be submitted by 13 June and will be published in a supplement of the Annals of Oncology.  Once the final version is available, please email wgiabstracts@imedex.com so we can provide you with late-breaking abstract submission instructions. 

Changes to Abstracts
You may change your abstract even after finalizing up until the submission deadline of 22 March 2021, 16:00 PM CET.  Once the submission site has closed, changes to abstracts will not be accepted.  

Abstract Withdrawal
Deadline for withdrawing abstracts is 26 April 2021.  The Congress cannot make any exceptions to this rule. 

Important Abstract Dates 
Abstract Submission Deadline 22 March 2021 at 16:00 CET
Disclosure Submission Deadline 22 March 2021 at 16:00 CET
Abstract Notifications Mailed 16 April 2021
Abstract Withdraw Deadline 26 April 2021
Abstract Presenter Registration Deadline 6 May 2021
Late-Breaking Abstract Deadline 13 June 2021
 
Support Desk/Questions?
Please click here to search our knowledgebase for articles.  You may also submit a support ticket if your question is not included in our articles.  Support tickets are answered within a 24hr period.


 


LOADING